ABL Diagnostics S.A Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 20, 2025 - 07:00 GMT

ABL Diagnostics and ELTA 90 Medical Science Win Tender to Deliver Whole Genome HIV Genotyping Solution in Montenegro

WOIPPY, FRANCE, November 20, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, announce that, together with its regional partner ELTA 90 Medical Science doo, it has been …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 18, 2025 - 17:00 GMT

ABL Diagnostics Presents Four Innovative Poster Studies at AMP 2025 Annual Meeting in Boston

Marking a Strategic Step Toward U.S. Commercial Launch WOIPPY, FRANCE, November 18, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce that the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 7, 2025 - 07:00 GMT

PREDAVIR : ABL Diagnostics et le CHRU Nancy unis pour prévenir les menaces virales grâce au FEDER Grand Est

Projet soutenu par l’Union européenne: Fonds européen de développement régional (FEDER) - programme Grand Est et Massif des Vosges FEDER-FSE+-FTJ 2021-2027 WOIPPY, FRANCE, November 7, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD), …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 4, 2025 - 17:00 GMT

ABL Diagnostics and VELA Dx Expand Strategic Partnership with Key Commercial and Technical Milestones in EMEA

WOIPPY, FRANCE, November 4, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, today announced several major developments in its partnership with VELA Diagnostics (VELA Dx …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on October 30, 2025 - 07:00 GMT

ABL Diagnostics Expands Collaboration with Université Grenoble Alpes and CHU Grenoble for Advanced HCV Testing

Delivering a Robust and Comprehensive HCV Genotyping and Resistance Testing Solution WOIPPY, FRANCE, October 30, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on October 22, 2025 - 16:00 GMT

ABL Luxembourg Announces Second Strategic Agreement with Alumni Capital to Support ABL Diagnostics’ Growth

ABL Diagnostics SA (EPA:ABLD) LUXEMBOURG VILLE, LUXEMBOURG, October 22, 2025 /⁨EINPresswire.com⁩/ -- Advanced Biological Laboratories S.A. (“ABL Luxembourg”) is pleased to announce the signing of a new share purchase agreement with Alumni Capital, a U.S.- …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on October 21, 2025 - 06:00 GMT

ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro

WOIPPY, FRANCE, October 21, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the appointment of two additional exclusive distribution partners to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on September 8, 2025 - 06:00 GMT

ABL Diagnostics partners with Eurobio Scientific UK to expand DeepChek® genotyping in UK & Ireland

WOIPPY, FRANCE, September 8, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signature of an exclusive distribution agreement with Eurobio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on September 3, 2025 - 06:00 GMT

ABL Diagnostics Demonstrates Unique DeepChek® Technology Across All NGS Platforms in Breakthrough Study

WOIPPY, FRANCE, September 3, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, today announced the results of a new peer-reviewed study published in LabMed (Martinez et al …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on August 6, 2025 - 16:00 GMT

ABL Announces a Share Purchase Agreement with Alumni Capital to Support the Business Development of ABL Diagnostics

LUXEMBOURG VILLE, LUXEMBOURG, August 6, 2025 /⁨EINPresswire.com⁩/ -- Advanced Biological Laboratories (ABL), a diagnostics company, headquartered in Luxembourg, today announced that it has entered into a share purchase agreement (SPA) with Alumni Capital …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 29, 2025 - 06:56 GMT

ABL Diagnostics to Become Exclusive Distributor of VELADX in EMEA for Molecular Diagnostics

WOIPPY, FRANCE, July 29, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the signing of an exclusive distribution agreement with VELA Operations …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on July 16, 2025 - 06:00 GMT

ABL Diagnostics Signs Distribution Agreement with Anatech to Expand Molecular Detection in South Africa, Southern Africa

WOIPPY, FRANCE, July 16, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce a distribution agreement with Anatech Instruments (Pty) Ltd (https:// …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 25, 2025 - 16:12 GMT

ABL Diagnostics announces the payment of its first dividend for the 2024 financial year

ABL Diagnostics announces its first dividend for 2024 since the 2022 merger that led activity in the field of genotyping diagnostics of infectious diseases ABL Diagnostics SA (ENX:ABLD) WOIPPY, MOSELLE, FRANCE, June 25, 2025 /⁨EINPresswire.com⁩/ -- The …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on June 4, 2025 - 06:00 GMT

ABL Diagnostics to Present Breakthrough Scientific Data at the European Meeting on HIV & Hepatitis 2025

Featuring New Advances in Automated Bioinformatics and HIV Drug Resistance Detection Using Next-Generation Sequencing WOIPPY, FRANCE, June 4, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 28, 2025 - 06:00 GMT

ABL Diagnostics Expands Verification of DeepChek® on Additional MGI NGS Platforms to Enhance Microbiology Genotyping

Now Offering Native Library Preparation Kits and Workflow Automation for MGI Instruments WOIPPY, FRANCE, May 28, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 21, 2025 - 06:00 GMT

ABL Diagnostics Successfully Verifies DeepChek® Assays & Software on Illumina’s MiSeq™ i100 & MiSeqDx Platforms

WOIPPY, FRANCE, May 21, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is proud to announce the successful verification of its DeepChek® Assays and Software Suite on …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 7, 2025 - 10:57 GMT

ABL Diagnostics to Increase Net Accounting Income Fivefold by 2024

A positive and increasing net accounting income in 2024, confirming ABL Diagnostics' ability to consolidate its historical activity ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, May 7, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics is a French …

Distribution channels: Business & Economy, Companies ...

Published on April 22, 2025 - 06:00 GMT

Advanced Biological Laboratories (ABL) S.A Inks Licensing Agreement with the Institut Pasteur for HPV RNA-Seq Technology

HPV Transcriptome as a Game-Changing Biomarker for Detection, Genotyping, and Monitoring of HPV-Associated Cervical High-Grade Cytology LUXEMBOURG, LUXEMBOURG, April 22, 2025 /⁨EINPresswire.com⁩/ -- Advanced Biological Laboratories (ABL), a diagnostics …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 2, 2025 - 06:00 GMT

ABL Diagnostics Signs Exclusive Distribution Agreement with Genient to Expand Microbiology Genotyping in India

WOIPPY, FRANCE, April 2, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. (https …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 17, 2025 - 07:00 GMT

ABL Diagnostics Signs Exclusive Distribution Agreement with Riken Genesis to Expand Microbiology Genotyping in Japan

WOIPPY, FRANCE, March 17, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Riken Genesis Co., Ltd. (https …

Distribution channels: Business & Economy, Companies ...